Rare diseases
Investigational molecules
Locations
Vrchlickeho 59, 586 01 Jihlava, Czechia
Hospital Jihlava in Jihlava, Czechia specialises in clinical trials of conditions such as Arteriosclerosis, Acute myocardial infarction, Muscle spasticity, Multiple sclerosis, and other specialisations. This site conducts important research.
The medical center is at the forefront of neurology research, with a particular focus on Multiple Sclerosis (MS). The institution is dedicated to advancing the understanding and treatment of this complex neurological disorder, which affects the central nervous system and can lead to a wide range of symptoms, including physical, mental, and sometimes psychiatric problems.
Through rigorous clinical trials, the center is exploring the efficacy and safety of innovative treatments such as CT-P53, aiming to provide new therapeutic options for patients with relapsing-remitting multiple sclerosis. This research not only seeks to establish the non-inferiority of new treatments compared to existing ones but also to enhance the pharmacological understanding of MS therapies.
Clinical trials currently enrolling participants at this site.
Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
CzechiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
CzechiaStudy on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury
CzechiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
CzechiaStudy Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
CzechiaStudy on Edoxaban for Patients with Atrial Fibrillation and Previous Brain Bleeding
CzechiaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
